CN103463413B - The decoction for the treatment of hypertrophy of tonsils - Google Patents

The decoction for the treatment of hypertrophy of tonsils Download PDF

Info

Publication number
CN103463413B
CN103463413B CN201310403446.4A CN201310403446A CN103463413B CN 103463413 B CN103463413 B CN 103463413B CN 201310403446 A CN201310403446 A CN 201310403446A CN 103463413 B CN103463413 B CN 103463413B
Authority
CN
China
Prior art keywords
radix
tonsils
hypertrophy
rhizoma
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310403446.4A
Other languages
Chinese (zh)
Other versions
CN103463413A (en
Inventor
黄福存
刘洁琼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310403446.4A priority Critical patent/CN103463413B/en
Publication of CN103463413A publication Critical patent/CN103463413A/en
Application granted granted Critical
Publication of CN103463413B publication Critical patent/CN103463413B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention relates to a kind of pharmaceutical formulation field, specifically a kind of decoction for the treatment of hypertrophy of tonsils, it is characterized in that raw material composition is by weight percentage: Radix Bupleuri 10 ~ 15%, Rhizoma Belamcandae 7 ~ 10%, cortex trichosanthis 8 ~ 10%, Cortex Phellodendri 1 ~ 3%, Radix Paeoniae Rubra 6 ~ 10%, Herba Violae 7 ~ 12%, Semen Vaccariae 6 ~ 9%, Radix Ophiopogonis 4 ~ 7%, Folium Eriobotryae 2 ~ 5%, Herba laggera 3 ~ 6%, Radix Saposhnikoviae 3 ~ 5%, Fructus Arctii 2 ~ 4%, Radix Asparagi 4 ~ 7%, Rhizoma Pinelliae 6 ~ 10%, Flos Gardeniae 2 ~ 6%, Rhizoma Et Radix Notopterygii 3 ~ 6%, by above-mentioned 16 taste crude drug, to remove slag to obtain after enduring with decocting filtrate.Cost of the present invention is low, and treatment hypertrophy of tonsils curative effect is high, has no side effect.Be not only applicable to acute and chronic hypertrophy of tonsils.

Description

The decoction for the treatment of hypertrophy of tonsils
Technical field
The present invention relates to a kind of Chinese patent medicine preparation, specifically a kind of decoction for the treatment of hypertrophy of tonsils.
Background technology
As everyone knows, hypertrophy of tonsils is Common Pediatric Diseases, and primary disease is mainly in 3-10 year child.How because of antibacterial or viral repeated infection nasopharynx part and the inflammation repetitious stimulation of adjoining position or proventriculus type self thereof, proventriculus type generation pathologic is bred.Clinical manifestation can have the high heat of infant, nasopharynx part dull pain, headache, general malaise, and nasal obstruction is serious, and with mouth breathing, send the sound of snoring when sleeping, severe patient can cause obstruction sleep apnea-hypopnea syndrome.Secretions stimulates respiratory mucosa, often causes apasm of coughing.Long-term mouth breathing, influence surface bone development, upper jaw bone is elongated, and palatine bone height arch, denture is uneven.Pharyngeal opening of auditory tube is obstructed, and the secretion physical property that can occur together otitis media, causes auditory dysesthesia and tinnitus, sometimes can cause suppurative otitis media.General Symptoms is mainly chronic poisoning and reflex neuro symptom.Show as nutritional development bad, bradykinesia, absent minded, fright at night, grind one's teeth in sleep, the enuresis etc.The clinical infant to hypertrophy of tonsils, except operative treatment, note preventing cold, improve immunity of organisms, expectant treatment etc. are process generally, cannot effect a radical cure, and brings painful and financial burden greatly to infant and family.
Summary of the invention
Object of the present invention is exactly that provide a kind of decoction for the treatment of hypertrophy of tonsils, cost is low in order to overcome above-mentioned existing technical deficiency, can exempt the misery of operative treatment, gently, treatment hypertrophy of tonsils curative effect is high for spirit, financial burden, have no side effect, be applicable to acute and chronic hypertrophy of tonsils.
The technical scheme that the present invention solves the problems of the technologies described above employing is: a kind of decoction for the treatment of hypertrophy of tonsils, it is characterized in that raw material composition is by weight percentage: Radix Bupleuri 10 ~ 15%, Rhizoma Belamcandae 7 ~ 10%, cortex trichosanthis 8 ~ 10%, Cortex Phellodendri 1 ~ 3%, Radix Paeoniae Rubra 6 ~ 10%, Herba Violae 7 ~ 12%, Semen Vaccariae 6 ~ 9%, Radix Ophiopogonis 4 ~ 7%, Folium Eriobotryae 2 ~ 5%, Herba laggera 3 ~ 6%, Radix Saposhnikoviae 3 ~ 5%, Fructus Arctii 2 ~ 4%, Radix Asparagi 4 ~ 7%, Rhizoma Pinelliae 6 ~ 10%, Flos Gardeniae 2 ~ 6%, Rhizoma Et Radix Notopterygii 3 ~ 6%, by above-mentioned 16 taste crude drug, to remove slag to obtain after enduring with decocting filtrate.
The invention has the beneficial effects as follows, cost is low, and treatment hypertrophy of tonsils curative effect is high, has no side effect.Be applicable to acute and chronic hypertrophy of tonsils.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described:
Embodiment 1:
Radix Bupleuri, Rhizoma Belamcandae, cortex trichosanthis, Cortex Phellodendri, Radix Paeoniae Rubra, Herba Violae, Semen Vaccariae, Radix Ophiopogonis, Folium Eriobotryae, Herba laggera, Radix Saposhnikoviae, Fructus Arctii, Radix Asparagi, Rhizoma Pinelliae, Flos Gardeniae, Rhizoma Et Radix Notopterygii is adopted to be that raw material is prepared from.It is Radix Bupleuri 12, Rhizoma Belamcandae 9, cortex trichosanthis 9, Cortex Phellodendri 2, Radix Paeoniae Rubra 9, Herba Violae 10, Semen Vaccariae 9, Radix Ophiopogonis 6, Folium Eriobotryae 4, Herba laggera 4, Radix Saposhnikoviae 3, Fructus Arctii 3, Radix Asparagi 5, Rhizoma Pinelliae 8, Flos Gardeniae 3, Rhizoma Et Radix Notopterygii 4 that its component (% by weight) often pays medicine.Getting above-mentioned 16 taste Chinese herbal medicine gross weights is 171 grams, at room temperature add water to about 1000ml, soak 4 ~ 5 hours, then boil slow fire with high heat and decoct to about 90 ~ 100 minutes, remove slag to obtain filtrate about 300ml, medicinal residues add water 200 ~ 300ml again, and decoct about 30 minutes, remove slag to obtain filtrate 100ml, be total to obtain about 400ml medicine juice, the i.e. decoction of obtained treatment hypertrophy of tonsils, load in sterile glass vials, seal bottle cap is for subsequent use.Every day, 2 ~ 3 empty stomaches were oral, and each serving 15 ~ 30ml, take and disappear to Clinical symptom and sign, position, nasopharynx x line side film making hypertrophy of tonsils disappears.
Radix Bupleuri of the present invention is bitter, is slightly cold.Return liver, gallbladder meridian.Reconciling superficies and interior, soothing the liver, yang invigorating.For cold, fever, alternate attack of chill and fever, distending pain in the chest and hypochondrium, menoxenia, sub-official's prolapsus, proctoptosis; The hot blood-cooling drugs of Rhizoma Belamcandae.Meridian distribution of property and flavor is bitter, cold, slightly poisonous.Heat-clearing and toxic substances removing, dispelling phlegm and relieving sore-throat, loose blood detumescence; Cortex trichosanthis is bitter, cold.Attach to the lung and stomach meridians.To regulate the flow of vital energy de-swelling: for distension and fullness of the chest and abdomen, the diseases such as distension and fullness in the abdomen; Cortex Phellodendri taste return through: bitter, cold.Return kidney, bladder, large intestine channel.Heat clearing and damp drying, eliminating fire and detoxication, bring down a fever except steam.Application: damp-heat vaginal discharge, pyretic stranguria beriberi, dysentery jaundice, skin infection swells and ache, eczema eczema; Radix Paeoniae Rubra has the functions such as clots absorbing, pain relieving, removing heat from blood, detumescence, controls the stagnant amenorrhea of the stasis of blood, hernia abdominal mass is gathered, suffers from abdominal pain, hypochondriac pain, epistaxis, dysentery, discharging fresh blood stool, conjunctival congestion, carbuncle, injury from falling down; Herba Violae is the Chinese herbal medicine of " heat-clearing and toxic substances removing ".Pharyngolaryngitis can be treated, the diseases such as skin papula; Semen Vaccariae bitter in the mouth, property is put down, and returns liver, stomach warp, enters blood system, directly and not keep, have effect of promoting blood circulation to restore menstrual flow, stimulating milk secretion eliminating carbuncle, inducing diuresis for treating stranguria syndrome; Radix Ophiopogonis YIN nourishing and the production of body fluid promoting, lung moistening clears away heart-fire.For dryness of the lung dry cough, deficiency of YIN consumptive disease is coughed, sore throat pharyngalgia, and Tianjin wound is thirsty, and interior-heat is quenched one's thirst, vexed insomnia, dryness of the intestine constipation; Folium Eriobotryae cold nature, bitter in the mouth. function cures mainly: clearing away lung-heat to relieve cough, stopping nausea and vomiting by lowering the adverse flow of QI. for cough due to lung-heat, QI rising in reverse order dyspnea with rapid respiration; Herba laggera heat-clearing and toxic substances removing.Control upper respiratory tract infection, tonsillitis, pharyngolaryngitis, stomatitis, bronchitis, malaria, carbuncle furuncle; Radix Saposhnikoviae is pungent, sweet, tepor.Return lung, bladder, liver, spleen channel; Fructus Arctii dispelling wind and heat pathogens lung qi dispersing rash resolving toxin and disinhibiting the throat, clinical practice: anemopyretic cold, epidemic febrile disease from the beginning of, cough with copious phlegm, measles without adequate eruption, rubella pruritus, carbuncle sore tumefacting virus, mumps erysipelas, laryngopharynx swelling and pain; Radix Asparagi is cold in nature, sweet in the mouth, micro-hardship.There is replenishing YIN and removing heat, effect of lung moistening nourishing kidney.For controlling fever due to yin deficiency, cough haematemesis, lung abscess, laryngopharynx swelling and pain, quenching one's thirst; Rhizoma Pinelliae has the function of drying dampness to eliminate phlegm, dissolving lump and resolving mass, has good effect to treatment damp-phlegm cold drink, vomiting, regurgitation, cough, abundant expectoration, headache sleeplessness etc.; Flos Gardeniae cures mainly calentura hyperpyrexia, dysphoria and insomnia, and excess-fire is had a toothache, aphtha of the mouth and tongue, and nose is advised, and spits blood, eye conjunctivitis, sore swollen toxin, icteric infectious hepatitis, favism, hematuria; Rhizoma Et Radix Notopterygii is induced sweat cold expelling, expelling wind and dampness, pain relieving, anemofrigid cold.Xin Wen disperses, and abnormal smells from the patient hero is strong, is good at rising distributing and shows there is the stronger cold expelling that induces sweat, expelling wind and dampness, the merit of pain relieving.Prescription is ingenious, drug effect mutual reinforcement between, makes two kinds of performances, the drug combination that effect is identical or approximate, with medicament curative effect enhancement, the drug effect mutual-assistance, multi-medicament compatibility, accessory drugs can improve principal agent effect, drug effect mutual restraint between two drugs, a toxic and side effects for medicine, suppress by another kind of medicine, make its toxic and side effects alleviate or disappear.Efficacy of drugs is the specially good effect of hypertrophy of tonsils.
The each raw material of the present invention also can the embodiment that mixes of ratio (percentage by weight) listed by according to the form below realize.Its processing technique is identical with embodiment 1.
Below in conjunction with my institute, the clinical preliminary test that namely No.2 People's Hospital, Rongcheng City carries out is done further the present invention, is described in detail:
1, case selection: this group 66 example, at 3 ~ 10 years old age, wherein the course of disease >=January 12 is routine, and >=March 31 is routine, and >=June 7 is routine, >=JIUYUE 26 example.Boy 37 example, girl 29 example.
2, Therapeutic Method: every day, 2 ~ 3 empty stomaches were oral, each serving 15 ~ 30ml, took 1 month.
3, the standard of curative effect evaluation: effective: the Clinical symptom and sign of hypertrophy of tonsils disappears, position, nasopharynx x line side film making hypertrophy of tonsils disappears; Effective: the Clinical symptom and sign of hypertrophy of tonsils alleviates, nasopharynx x line film making hypertrophy of tonsils reduces; Invalid: the Clinical symptom and sign of hypertrophy of tonsils and nasopharynx x line film making hypertrophy of tonsils are without change.Effective adding is effectively total effective rate.
4, therapeutic effect: use the present invention to treat decoction treatment 66 example of hypertrophy of tonsils, effective 53 examples, account for 80.3%, and effective 11 examples, account for 16.7%, and invalid 2 examples, account for 3%, and always effective 64 examples, account for 97%.

Claims (1)

1. treat the decoction of hypertrophy of tonsils for one kind, it is characterized in that raw material composition is by weight percentage: Radix Bupleuri 10 ~ 15%, Rhizoma Belamcandae 7 ~ 10%, cortex trichosanthis 8 ~ 10%, Cortex Phellodendri 1 ~ 3%, Radix Paeoniae Rubra 6 ~ 10%, Herba Violae 7 ~ 12%, Semen Vaccariae 6 ~ 9%, Radix Ophiopogonis 4 ~ 7%, Folium Eriobotryae 2 ~ 5%, Herba laggera 3 ~ 6%, Radix Saposhnikoviae 3 ~ 5%, Fructus Arctii 2 ~ 4%, Radix Asparagi 4 ~ 7%, Rhizoma Pinelliae 6 ~ 10%, Flos Gardeniae 2 ~ 6%, Rhizoma Et Radix Notopterygii 3 ~ 6%, by above-mentioned 16 taste crude drug, filtrate of removing slag to obtain after enduring with decocting.
CN201310403446.4A 2013-08-27 2013-08-27 The decoction for the treatment of hypertrophy of tonsils Expired - Fee Related CN103463413B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310403446.4A CN103463413B (en) 2013-08-27 2013-08-27 The decoction for the treatment of hypertrophy of tonsils

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310403446.4A CN103463413B (en) 2013-08-27 2013-08-27 The decoction for the treatment of hypertrophy of tonsils

Publications (2)

Publication Number Publication Date
CN103463413A CN103463413A (en) 2013-12-25
CN103463413B true CN103463413B (en) 2016-03-30

Family

ID=49788605

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310403446.4A Expired - Fee Related CN103463413B (en) 2013-08-27 2013-08-27 The decoction for the treatment of hypertrophy of tonsils

Country Status (1)

Country Link
CN (1) CN103463413B (en)

Also Published As

Publication number Publication date
CN103463413A (en) 2013-12-25

Similar Documents

Publication Publication Date Title
CN100553664C (en) A kind of Chinese medicine composition of oral administration for treating chronicity pharyngitis
CN102872359B (en) Traditional Chinese medicine composition for treating chronic cholecystitis
CN103877429A (en) Traditional Chinese medicine preparation for treating nasosinusitis and preparation method of traditional Chinese medicine preparation
CN104784548A (en) Traditional Chinese medicine composition for treating cough and application thereof
CN102091279B (en) Traditional Chinese medicine composition for treating duodenal ulcer
CN102138977B (en) Baizhi Xiner decoction for adenoid vegetation
CN103071142B (en) Quick-acting external patch for tracheitis
CN103463413B (en) The decoction for the treatment of hypertrophy of tonsils
CN105797063A (en) Orally taken medicine for treating gallstones and preparation method thereof
CN104606533A (en) Traditional Chinese medicine decoction for treating pharyngitis
CN104225558A (en) Quick-acting external use patch for pneumonia and preparation method thereof
CN103494986B (en) The Chinese medicine for the treatment of primary trigeminal neuralgia
CN103550622B (en) A kind of Chinese medicine for stopping postpartum milk secretion
CN104491391A (en) Traditional Chinese medicine composition for treating pharyngitis
CN104873836A (en) Otitis media suppurativa treatment external use medicine and preparation method
CN105796992A (en) Oral liquid for effective treatment of oral ulcer
CN104258223A (en) Traditional Chinese medicine for treating pulmonary tuberculosis
CN105663657A (en) Decoction medicine capable of effectively treating fire excess from yin deficiency and preparation method thereof
CN104258177A (en) Traditional Chinese medicine for treating lung abscess
CN103585579B (en) A kind of Chinese medicine for the treatment of fracture and preparation method thereof
CN105477472A (en) Medicament for treating periodontitis
CN104337922A (en) Chinese medicine preparation for nursing acute tonsillitis and preparation method
CN104069291A (en) Traditional Chinese medicine for treating facioplegia
CN104474253A (en) Traditional Chinese medicine composition for treating chronic rhinitis
CN103977156A (en) Chinese medicine for treating intractable hiccup

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160330

Termination date: 20160827

CF01 Termination of patent right due to non-payment of annual fee